Risk assessment for coronary heart disease in rheumatoid arthritis and osteoarthritis.
about
Role of adipokines in atherosclerosis: interferences with cardiovascular complications in rheumatic diseasesRheumatoid arthritis, cardiovascular disease and physical exercise: a systematic review.Prevalence, incidence and characteristics of the metabolic syndrome (MetS) in a cohort of Mexican Mestizo early rheumatoid arthritis patients treated with conventional disease modifying anti-rheumatic drugs: the complex relationship between MetS andApolipoprotein-A1 as a damage-associated molecular patterns protein in osteoarthritis: ex vivo and in vitro pro-inflammatory propertiesPrenatal caffeine exposure induces a poor quality of articular cartilage in male adult offspring rats via cholesterol accumulation in cartilage.Hypertension in rheumatoid arthritis.Uric acid is a strong independent predictor of renal dysfunction in patients with rheumatoid arthritisCardiometabolic comorbidities and rheumatic diseases: focus on the role of fat mass and adipokines.Evidence-based risk assessment and recommendations for physical activity: arthritis, osteoporosis, and low back pain.Prenatal food restriction induces poor-quality articular cartilage in female rat offspring fed a post-weaning high-fat diet and its intra-uterine programming mechanisms.Risk factors for cardiovascular disease and future osteoarthritis-related arthroplasty: a population-based cohort study in men and women from Malmö, Sweden.Galectin-2 (LGALS2) 3279C/T polymorphism may be independently associated with diastolic blood pressure in patients with rheumatoid arthritis.Differences in the prevalence and characteristics of metabolic syndrome in rheumatoid arthritis and osteoarthritis: a multicentric study.Lack of an association of GNB3 C825T polymorphism and blood pressure in patients with rheumatoid arthritis.Predictors of endothelial dysfunction in patients with rheumatoid arthritis.Cardiovascular disease in rheumatoid arthritis: medications and risk factors in China.Effects of a 12-week cardiovascular rehabilitation programme on systemic inflammation and traditional coronary artery disease risk factors in patients with rheumatoid arthritis (CARDIA trial): a randomised controlled trial.Association between osteoarthritis and dyslipidaemia: a systematic literature review and meta-analysis.Baicalin reduces blood lipids and inflammation in patients with coronary artery disease and rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial.
P2860
Q27008359-603DBFA8-176F-4F7A-9329-6BA6A290C0FCQ33307666-87B8913A-11D4-4201-8BA6-0D4AD61073C4Q35185494-73417119-BBF0-487A-B527-87679FFFD796Q35303738-997C2EE8-1121-4B01-92F0-71FCAEC9C9C5Q36350197-F563340E-0531-4069-A9D3-73D704FF4E9AQ37158219-E101C55B-5151-4239-BE44-540B87362838Q37350911-FC50AA22-0CD1-4D40-94DD-AECCFFC49C9DQ37869467-1A7B52FC-0C15-47F3-8D13-FB06144F02DCQ37908104-F28DF3E1-FEBE-468D-8B40-2729A1BB9430Q39343625-328990BA-34DF-4F1A-9DA5-DABBEDD5DCEAQ39705426-DE8DA03C-3000-4491-848D-D2D5D76BBEF7Q39991479-183EBB7B-DA0E-4B44-8714-B51ACDC7C26BQ41682577-571B77BB-F43F-4E96-A859-8BD336C062C9Q44438694-A56BB39A-67D5-46AF-AD65-BB5605F9AA21Q44832625-F37BAF88-3BDD-4B1C-876F-D7AF134B2561Q47940789-FDC5E694-B30E-4CDF-BE43-317F7861B8DFQ49282700-757B0823-AECF-4EA9-982C-7EE8B51236B2Q49441836-59CFB962-D7EC-4BA8-8B30-07D1C927C657Q55413719-BB3AF96F-2084-4E09-8447-F496BF8168A6
P2860
Risk assessment for coronary heart disease in rheumatoid arthritis and osteoarthritis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Risk assessment for coronary heart disease in rheumatoid arthritis and osteoarthritis.
@en
Risk assessment for coronary heart disease in rheumatoid arthritis and osteoarthritis.
@nl
type
label
Risk assessment for coronary heart disease in rheumatoid arthritis and osteoarthritis.
@en
Risk assessment for coronary heart disease in rheumatoid arthritis and osteoarthritis.
@nl
prefLabel
Risk assessment for coronary heart disease in rheumatoid arthritis and osteoarthritis.
@en
Risk assessment for coronary heart disease in rheumatoid arthritis and osteoarthritis.
@nl
P2093
P2860
P1476
Risk assessment for coronary heart disease in rheumatoid arthritis and osteoarthritis.
@en
P2093
P2860
P304
P356
10.1080/03009740410006899
P577
2004-01-01T00:00:00Z